Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 91 citing articles:

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
Mark Dittmar, Jae Seung Lee, Kanupriya Whig, et al.
Cell Reports (2021) Vol. 35, Iss. 1, pp. 108959-108959
Open Access | Times Cited: 225
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
Yahya Mahamat‐Saleh, Thibault Fiolet, Mathieu E. Rebeaud, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e052777-e052777
Open Access | Times Cited: 166
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19
Fasihul Khan, Iain Stewart, Laura Fabbri, et al.
Thorax (2021) Vol. 76, Iss. 9, pp. 907-919
Open Access | Times Cited: 117
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
Jason D. Goldman, Philip C. Robinson, Thomas S. Uldrick, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 6, pp. e002630-e002630
Open Access | Times Cited: 106
A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity
Rebecca Dowey, Ahmed Iqbal, Simon Heller, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19
Essa M. Saied, Yousra A. El‐Maradny, Alaa A. Osman, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1759-1759
Open Access | Times Cited: 58
Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
Maryam Al‐Nesf, Houari Abdesselem, Ilham Bensmail, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Active Smokers Are at Higher Risk of COVID-19 Death: A Systematic Review and Meta-analysis
Roengrudee Patanavanich, Tanatorn Siripoon, Salin Amponnavarat, et al.
Nicotine & Tobacco Research (2022) Vol. 25, Iss. 2, pp. 177-184
Open Access | Times Cited: 40
The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis
Guangyu Ao, Yushu Wang, Xin Qi, et al.
Transplantation Reviews (2021) Vol. 35, Iss. 3, pp. 100628-100628
Open Access | Times Cited: 52
A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity
Jie Xu, Wenwei Xiao, Xuan Liang, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 50
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update
Imad M. Tleyjeh, Zakariya Kashour, Muhammad Riaz, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1076-1082
Open Access | Times Cited: 43
Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants
Claudio Fenizia, Silvia Galbiati, Claudia Vanetti, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Interventions for the prevention and treatment of COVID-19: a living mapping of research and living network meta-analysis
Isabelle Boutron, Anna Chaimani, Declan Devane, et al.
Cochrane library (2020)
Open Access | Times Cited: 39
Clinical Significance of Plasma D-Dimer in COVID-19 Mortality
LI Yayun, Yuhao Deng, Lin Ye, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 34
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group
Judith Schaffrath, Christina Brummer, Daniel Wolff, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 6, pp. 337.e1-337.e10
Open Access | Times Cited: 23
Intensive Care and Organ Support Related Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis
Abhimanyu Chandel, Sahar Leazer, Karl C. Alcover, et al.
Critical Care Explorations (2023) Vol. 5, Iss. 3, pp. e0876-e0876
Open Access | Times Cited: 13
A systematic review and meta-analysis of Anakinra, Sarilumab, Siltuximab and Tocilizumab for Covid-19
Fasihul Khan, Iain Stewart, Laura Fabbri, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 32
Gender inequality and health disparity amid COVID-19
Zhaohui Su, Ali Cheshmehzangi, Dean McDonnell, et al.
Nursing Outlook (2021) Vol. 70, Iss. 1, pp. 89-95
Open Access | Times Cited: 27
Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
Xinlei Li, Tao Peng
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity
Andrea Spini, Valentina Giudice, Vincenzo Brancaleone, et al.
Pharmacological Research (2021) Vol. 173, pp. 105848-105848
Open Access | Times Cited: 23
Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)
Chongxiang Chen, Fang‐Wen Hu, Jin Wei, et al.
Leukemia (2021) Vol. 35, Iss. 6, pp. 1661-1670
Open Access | Times Cited: 22
Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine
Kartikay Prasad, Shahzaib Ahamad, Kanipakam Hema, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 5, pp. 930-944
Closed Access | Times Cited: 21
Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry
Jorge Calderón‐Parra, Valentín Cuervas‐Mons, Víctor Moreno‐Torres, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 51-58
Open Access | Times Cited: 21
Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection
Lucie Sauerhering, И. Л. Кузнецова, Alexandra Kupke, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 205, Iss. 8, pp. 964-968
Open Access | Times Cited: 15
A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19
Vinicius M. Fava, Mathieu Bourgey, Pubudu M. Nawarathna, et al.
Science Advances (2022) Vol. 8, Iss. 22
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top